Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Annals of Palliative Medicine|July 15, 2021
Palliative surgery and the surgeon's role in the palliative care team: a reviewAnna D Louie, Thomas J MinerFrontiers in Pharmacology|November 5, 2021
Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer TherapeuticsAnna D Louie, Kelsey Huntington, Lindsey Carlsen, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 30, 2021
Providing Appropriate Pancreatic Cancer Care for People Experiencing Homelessness: A Surgical PerspectiveAnna D Louie, Chibueze A Nwaiwu, Julia Rozenberg, et al.Elife|January 14, 2021
Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2Kelsey E Huntington, Anna D Louie, Chun Geun Lee, et al.Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients with COVID-19Kelsey E Huntington, Anna D Louie, Chun Geun Lee, et al.American Journal of Cancer Research|February 14, 2025
TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse model of pancreatic ductal adenocarcinomaAnna D Louie, Kelsey E Huntington, Young Lee, et al.Pediatric Radiology|February 17, 2025
Use of photon-counting CT and three-dimensional printing for an intra-thoracic retained ballistic fragment in a 9-year-oldCatherine B Beckhorn, Mary E Moya-Mendez, Michael Aiduk, et al.Cancer|May 6, 2025
Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancerMichael S Lee, Samantha M Thomas, Anna D Louie, et al.International Journal of Molecular Sciences|July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal CancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.Pageof 2